Edwards Lifesciences (EW)

R&D to Revenue

16.02%

Quarterly · Period ending:

EW logo

EW R&D to Revenue

Latest reported16.02%
EW Quarterly R&D/Revenue (7.26% → 16.02%)
High-resolution chart · PNG

EW r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Edwards Lifesciences R&D to Revenue — Quarterly
Period endingR&D to Revenue
7.0166%
6.8265%
6.7898%
6.9429%
6.8293%
6.1947%
7.265%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.